Christopher B. Benton

2.4k total citations
56 papers, 1.1k citations indexed

About

Christopher B. Benton is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Christopher B. Benton has authored 56 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hematology, 21 papers in Genetics and 16 papers in Molecular Biology. Recurrent topics in Christopher B. Benton's work include Acute Myeloid Leukemia Research (41 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Christopher B. Benton is often cited by papers focused on Acute Myeloid Leukemia Research (41 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Christopher B. Benton collaborates with scholars based in United States, Switzerland and Spain. Christopher B. Benton's co-authors include Guillermo Garcia‐Manero, Hagop M. Kantarjian, Farhad Ravandi, Jörge E. Cortes, Courtney D. DiNardo, Naveen Pemmaraju, Kapil N. Bhalla, Naval Daver, Tapan M. Kadia and Elias Jabbour and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Christopher B. Benton

55 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher B. Benton United States 17 682 475 250 237 234 56 1.1k
Marianne Rissler Sweden 15 565 0.8× 322 0.7× 212 0.8× 219 0.9× 187 0.8× 32 1.0k
Steve Kornblau United States 10 1.2k 1.7× 222 0.5× 369 1.5× 404 1.7× 253 1.1× 16 1.4k
Friedrich Schuening United States 21 617 0.9× 195 0.4× 198 0.8× 277 1.2× 174 0.7× 61 1.0k
Gary Calandra United States 15 1.1k 1.7× 307 0.6× 693 2.8× 500 2.1× 199 0.9× 41 1.7k
Abdul Hamid Bazarbachi United States 14 550 0.8× 388 0.8× 479 1.9× 153 0.6× 107 0.5× 30 878
Jeroen G. te Marvelde Netherlands 12 620 0.9× 361 0.8× 202 0.8× 239 1.0× 155 0.7× 20 1.0k
Sergio Matarraz Spain 19 475 0.7× 298 0.6× 98 0.4× 264 1.1× 204 0.9× 38 931
Uta Oelschlägel Germany 22 1.2k 1.7× 428 0.9× 488 2.0× 635 2.7× 392 1.7× 53 1.8k
Masaaki Takatoku Japan 18 658 1.0× 528 1.1× 323 1.3× 135 0.6× 327 1.4× 47 1.1k
Emily Curran United States 16 220 0.3× 278 0.6× 201 0.8× 263 1.1× 119 0.5× 42 765

Countries citing papers authored by Christopher B. Benton

Since Specialization
Citations

This map shows the geographic impact of Christopher B. Benton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher B. Benton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher B. Benton more than expected).

Fields of papers citing papers by Christopher B. Benton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher B. Benton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher B. Benton. The network helps show where Christopher B. Benton may publish in the future.

Co-authorship network of co-authors of Christopher B. Benton

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher B. Benton. A scholar is included among the top collaborators of Christopher B. Benton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher B. Benton. Christopher B. Benton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manda, Sudhir, Bertrand Anz, Christopher B. Benton, et al.. (2024). A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia. Hematological Oncology. 42(3). e3274–e3274. 6 indexed citations
2.
3.
Benton, Christopher B., Michael R. Grunwald, Hana Safah, & Margaret Kasner. (2022). Co-management strategies for acute myeloid leukemia patients in the community setting. Frontiers in Oncology. 12. 1060912–1060912. 2 indexed citations
4.
Benton, Christopher B., et al.. (2021). Two Cases of Possible Familial Chronic Myeloid Leukemia in a Family with Extensive History of Cancer. Acta Haematologica. 144(5). 585–590. 5 indexed citations
5.
Manda, Sudhir, Bertrand Anz, Christopher B. Benton, et al.. (2021). Treatment Initiation of Venetoclax in Combination with Azacitidine or Decitabine in an Outpatient Setting in Patients with Untreated Acute Myeloid Leukemia. Blood. 138(Supplement 1). 1265–1265. 3 indexed citations
6.
Daver, Naval, Christopher B. Benton, Keyur P. Patel, et al.. (2020). First Report of Sorafenib in Patients With Acute Myeloid Leukemia Harboring Non-Canonical FLT3 Mutations. Frontiers in Oncology. 10. 1538–1538. 3 indexed citations
7.
Quesada, Andres, Mark J. Routbort, Courtney D. DiNardo, et al.. (2019). DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high‐risk disease. American Journal of Hematology. 94(7). 757–766. 71 indexed citations
8.
Benton, Christopher B., Prajwal Boddu, Courtney D. DiNardo, et al.. (2019). Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia. Cancer. 125(11). 1855–1866. 27 indexed citations
9.
10.
Chamoun, Kamal, Sanam Loghavi, Naveen Pemmaraju, et al.. (2018). Early detection of transformation to BPDCN in a patient with MDS. Experimental Hematology and Oncology. 7(1). 26–26. 13 indexed citations
11.
Daly, Elizabeth R., et al.. (2017). An Outbreak of Invasive Group A Streptococcal Infections in Injection Drug Users. Open Forum Infectious Diseases. 4(suppl_1). S241–S241. 2 indexed citations
12.
DiNardo, Courtney D., Caitlin R. Rausch, Christopher B. Benton, et al.. (2017). Clinical experience with the BCL2‐inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies. American Journal of Hematology. 93(3). 401–407. 293 indexed citations
13.
Rausch, Caitlin R., Courtney D. DiNardo, Tapan M. Kadia, et al.. (2017). Results of Off-Label Venetoclax Use in Combination with Low-Intensity Chemotherapy in Patients with Relapsed and Refractory Myeloid Malignancies. Blood. 130. 1356–1356. 3 indexed citations
14.
Benton, Christopher B., Maliha Khan, Graciela Nogueras González, et al.. (2017). Sequential Stratification Prognostic Score for Patients with Intermediate-Risk Myelodysplastic Syndrome. Blood. 130. 4265–4265. 1 indexed citations
15.
Boddu, Prajwal, Hagop M. Kantarjian, Farhad Ravandi, et al.. (2017). Outcomes By Treatment Setting and Genomic Profile in Patients with AML on Cladribine, Idarubicin, and Cytarabine. Blood. 130. 3898–3898. 4 indexed citations
16.
Assi, Rita, Christopher B. Benton, Kamal Chamoun, et al.. (2017). JAK3 Variants in Adults with Myeloid Malignancies and Potential for Response to JAK3 Inhibition. Blood. 130. 1381–1381. 1 indexed citations
17.
Benton, Christopher B., Warren Fiskus, & Kapil N. Bhalla. (2017). Targeting Histone Acetylation. The Cancer Journal. 23(5). 286–291. 29 indexed citations
18.
Benton, Christopher B., Catherine Wilson, Sherry Pierce, et al.. (2015). Increased likelihood of post-polycythemia vera myelofibrosis in Ph-negative MPN patients with chromosome 12 abnormalities. Leukemia Research. 39(4). 419–423. 8 indexed citations
19.
Ruvolo, Peter P., Vivian Ruvolo, Christopher B. Benton, et al.. (2015). Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1863(4). 562–571. 37 indexed citations
20.
Benton, Christopher B., Aziz Nazha, Naveen Pemmaraju, & Guillermo Garcia‐Manero. (2015). Chronic myelomonocytic leukemia: Forefront of the field in 2015. Critical Reviews in Oncology/Hematology. 95(2). 222–242. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marianne Rissler Breakdown of academic impact, for papers by Steve Kornblau Breakdown of academic impact, for papers by Friedrich Schuening Breakdown of academic impact, for papers by Gary Calandra Breakdown of academic impact, for papers by Abdul Hamid Bazarbachi Breakdown of academic impact, for papers by Jeroen G. te Marvelde Breakdown of academic impact, for papers by Sergio Matarraz Breakdown of academic impact, for papers by Uta Oelschlägel Breakdown of academic impact, for papers by Masaaki Takatoku Breakdown of academic impact, for papers by Emily Curran
Rankless by CCL
2026